Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Dr. Ichim is no dummy.
http://www.usatoday.com/story/nation/2014/10/26/defense-threat-reduction-agency-ebola-treatment/17954499/
"Specifically, DTRA is seeking products that can be accelerated towards clinical evaluation in the near-term (3 to 6 months) to provide additional (medical countermeasure) capabilities to mitigate the epidemic in West Africa," the document says.
http://www.google.com/patents/WO2009035804A2?cl=en0089]
The template polynucleotides of the invention can be cloned into vectors, including but not limited to plasmid, cosmid, phagemid, and viral vectors according to well-known methods. The vectors can then be introduced into target cells that express BORIS where e.g, the siRNA produced therefrom directs cleavage of BORIS mRNA and thereby inhibits BORIS expression. The skilled artisan will appreciate that bacterial, bacteriophage, insect, fungal and other non-mammalian vectors may provide suitable templates for introduction into cultured mammalian cells. For clinical applications, a vector capable of persistence in the target cell, such as a viral vector, may be more desirable. Viral vectors also offer the advantage of efficient transfer of the template polynucleotide into the cell via infection rather than transfection. Exemplary viral vectors for clinical applications of the invention include but are not limited to adenoviruses, adeno-associated viruses, retroviruses, lentiviruses, vaccinia viruses, herpes viruses, and papilloma viruses.
http://www.nytimes.com/2014/10/28/science/ebola-and-the-vast-viral-universe.html
Viruses also work tirelessly to evade the immune system that seeks to destroy them. One of the deadliest features of the Ebola virus is its capacity to cripple the body’s first line of defense against a new pathogen, by blocking the release of interferon.
“That gives the virus a big advantage to grow and spread,” said Christopher F. Basler, a professor of microbiology at Mount Sinai School of Medicine.
At the same time, said Aftab Ansari of Emory University School of Medicine, the virus disables the body’s coagulation system, leading to uncontrolled bleeding. By the time the body can rally its second line of defense, the adaptive immune system, it is often too late.
Yet the real lethality of Ebola, Dr. Ansari said, stems from a case of mistaken location, a zoonotic jump from wild animal to human being. The normal host for Ebola virus is the fruit bat, in which the virus replicates at a moderate pace without killing or noticeably sickening the bat.
“A perfect parasite is able to replicate and not kill its host,” Dr. Ansari said. “The Ebola virus is the perfect parasite for a bat.”
Correction: October 28, 2014
I have a feeling that INtellicell will rise from the ashes. I continue to sell Plasma. Each time I do, I buy another 100,000 shares.
GRIFOLS
We need you! Life-saving medications produced from plasma can give the gift of healthy, normal lives to patients and their families around the world.
Receive up to $240 every month. It's safe and easy to donate blood-plasma.
Some of us just pray.
This is my analysis as well. Well, you used MBA terms, but common sense reveals truth.
Buy 100000 SVFC @ 0.0001 Lmt Day Canceled
THIS IS WHAT I ALWAYS SEE! :(
Totally agree with you--which is why it would be a good idea for Intellicell to be sold out to a savvy science-minded investor who can pay off YA Global.
There is NO way Dr. Andrews is going to let that happen--imho.
Thanks for that write up--new friend. I noted those past tense action verbs as well, which is why I bought more.
I bought a couple hundred thousand more today, the price of a couple dozen lotto tickets. This is a lotto play, but I believe in the science. I communicated via Twitter with Dr. Victor a few months ago, who privately expressed concern about my mother's severe paralysis autoimmune condition. Here was a busy CEO--navigating two companies-who took time to express his concern and his hope in science.
This man services the wealthy elite in his private practice, as well as sports players with deep pockets, yet he wrote me a personal note.
I am well aware that a fool and his money are soon parted, but I believe in this man's vision of the future of health care science. And, I consider my investment a donation. If I have to write it off--so be it, I would have given it to a charity anyway. The deductions for losses are similar.
I am angered by YA's attempts to seize control of this science--wresting the science away from the visionary scientist.
Riding high with a buyout would be great. I have 1.5 million shares. But, seeing my mom and my friend with Alzheimer's improve would be worth every penny sans return.
JMHO
Best wishes to all!
We seem to have lost nearly a year. C'Mon Kallo. Communicate something positive!
Friday, December 19th is my guess.
CEO Antonio Estabanell EDM
"We have used the falls to get more Grifols and Applus"
BEGOÑA BEARD ALBA MADRID 10.20.2014 7:33
Recommend on Facebook 2Tweet 8Send to LinkedIn 5
PRINT OUT
Related Topics:
EDM ManagementGrifolsGathered TechniquesIndraCatalana OccidenteMutual fundsFinancial marketsBusinessEconomyFinance
Estabanell Antonio, CEO of EDM.
MARTA YORDI
It is one of the oldest Spanish managers, with 25 years of life. Of Catalan origin, a specialist in Spanish and European equities and a pioneer in alternative investment. In late September administered 2,400 million.
Question. What are the main strengths of EDM?
Answer . Independence. Our sole aim is to offer good long-term results for our clients. As managers we have a selection based on individual assets in the portfolio, looking for companies that can grow, having good fundamental valuations but paying the right price style.
Q. After a week of vertigo in the stock market, do you think that falls mark a turnaround or are punctual?
R. 're in a very nervous market, which at the slightest wobble there are important corrections for psychological reasons we are nothing more than opportunities. We have seized falls to reinforce positions in securities with good long-term prospects, as Grifols, Applus, Essentra or Aggreko.
Q. How will behave markets?
R . We believe that given the situation in Europe, with such stagnant growth, monetary policy rates so low, rather than a country approach will be a large scatter in the prices of securities. We can have the stock of a country with shares having an excellent behavior with other nefarious behavior. The banking sector will behave similarly in different countries, since their results depend more on how the macroeconomic situation work.
Q. What are your favorite settings?
R . A value that is strongly Acerinox have bet, because it is a company that has done its homework. We like, as I said, Grifols, Catalana Occidente, Techniques Gathered and Indra. We believe that good deeds give good long-term results. We currently have more Spanish portfolio values ??at other times.
Q. And in Europe, what are your bets?
R . We weighted Roche. We see great opportunities in Capita Group, British company outsourcing and the German software giant SAP.
Q. In your opinion, how does the behavior of the bond?
R . The situation will be fixed very low yields for some time. The investor has to be aware of the environment in which we are, which are very low and even negative inflation. You have to look at real interest rates.
P. His connection to Catalonia, do you harm?
R . We do not position ourselves as a manager of Catalonia. We deposited vehicles in Ireland and Luxembourg. Our investment scope is global. The fact that our management team is in Barcelona is an anecdote.
Q. What changes in taxation?
R . We positively lowering of taxation on capital gains. Regarding income, we do not believe that there will be much decrease in taxation of the middle segments of the tax. Regarding Plan May expect their development. It does not seem very attractive need to be transformed into an annuity. We believe that increase individual pension funds.
EDM Management is present in Spain, Ireland, Luxembourg and the past year in Latin America funds sold through two American trading platforms, Pershing and DBH.
Q. Why have entered Latin America?
R. We felt that our expertise in security selection and management style was transferable to that geographical area initially but European values ??have launched a fund that invests in Latin American stocks. We manage 200 million euros there.
Q. What values ??provide more travel puddle jumping?
R . Dufry, a company of Swiss origin, but gives sales services in major Latin American airports. We also betting on the Brazilian bank Itaú and cosmetics firm Natura. And in Chile Falabella.
P. The political situation in Venezuela, Bolivia or Argentina, can affect the Spanish firms involved in the markets?
R. There are important uncertainties for companies operating in those countries. However, the consolidation of political systems can have very sustained growth in Peru, Colombia and Mexico.
P. Son of the pioneers in alternative investment, this business is dead?
R. With the financial crisis has changed much alternative investments. For private banks is probably dead because it is difficult to understand for the customer, but not for institutions. The volume of assets between institutional has increased and currently manage 80 million euros.
I think there is wisdom in what you say here. The FDA is backed up so much already and Ebola certainly has more traction than...breast cancer. I mean-I think people pink just like the color instead of that whole cancer awareness thing.
Our govt. will once again get bogged down in Red Tape. By the time the feds get to us, it will be pink tape.
I agree that our govt. cannot manage two health dilemmas at once.
Gem,
I am betting that you are right, else why bother with the nickel and dime financial restatements? To me, this does not feel like a company headed to no bid. It just has TOO much going for it right now.
FDA IND approval soon!
AN update would be nice.
Have trouble achieving that perfect rock-solid erection?
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895916/Abstract
Introduction
Adipose derived stem cells (ADSCs) are a somatic stem cell population contained in fat tissue that possess the ability for self-renewal, differentiation into one or more phenotypes and functional regeneration of damaged tissue, which will benefit the recovery of erectile function by using a stem cell based therapy.
Ask yourself why are they so confident in a profit. Could it be data from Phase III looks positive>?
Dividend present by December. Wooohhooo!
I think you should investigate Dinosaur Capital. Connections matter--and connection in multiple continents matter even more. I expect the EU patent will be approved VERY soon. Then, we merge with the big boys.
Unless, of course, you have shorts who still have yet to cover. Then, we could fly--like it flew to a penny a few months ago. Lots of new buyers today who smell a run.
The tech here is AMAZING!!
http://vimeo.com/108156552
Don't forget this Hoge video.
I now have a million shares.
I'll have to give a lot of plasma, but it will be worth it!!
DINOSOAR BABY!!!
I buy 100,000 shares after every two trips to donate my plasma.
YA has bled me dry, but I'll be damned if I let this great potential head to No Bid.
I have .02 shares from 500. How is this even legal? Greek Robber Barons!
$19,277.00 The price per share I need to recoup my intial investment
NEWL NEWLEAD HOLDINGS LTD SHS NEW $0.0490 +$0.007
(16.67%) 0.0200 $0.0010 $19,277.00 $385.54 -$385.54
(-100.00%)
In my IRA, too. I hate these Greek ripoff artists.
C'Mon WHO! You are now my/our only hope.
Thanks, gem!
Not happy about the downward spiral--but I think that the old adage it takes money to make money always applies. In this case, it takes capital to return on capital.
Holding just over half a million.
https://www.yahoo.com/health/how-plasma-transfusions-from-survivors-fight-ebola-99999106587.html
Who is the plasma leader in the WORLD?
Grifols
I am so disheartened. This technology could change the world of medicine.
I don't know about a scam. I think they wanted to be in place well before this Ebola crisis, which has drained the budgets of these African countries--their past core focus.
Now, my guess, is that it is Medical Software or bust for this company.
Regardless, the risk/reward ratio was great for a reason. I just wish this one had gone the other way. Waiting for end of December for the tax loss.
The theory behind the transfusion treatment is this: The blood of an Ebola survivor should carry antibodies of the virus. By giving a current Ebola patient an injection of a compatible amount of blood plasma from someone who recovered from the disease, those antibodies could help the patient fight the virus.
http://www.washingtonpost.com/news/to-your-health/wp/2014/10/08/ebola-survivor-kent-brantly-donates-blood-to-help-treat-nbc-cameraman-ashoka-mukpo/
C'MON GRIFOLS!!!!!!!
Hello,
I am excited about the potential for Grifolis' Alzheimer's treatments.
I see this stock doubling in a year!
Agreed. I see great potential with these treatments. Haven't sold a dime.
Once Intellicell starts running, my glass will be full with a tall cold mug of Olde Mecklenburg ale.
You know, in the end, it really is all about luck.
Sensible post.
Thanks!
Your post illuminates the risk/reward nature of this stock. You predict risk and loss. I predict risk and reward. Most here are investors b/c we know and care about people who will reap quality of life improvements from the Dr. Victor's invention.
My understanding is the same. The fda sply wants to double check the data, esp since the target population focuses on children.
Thank you for this post. Sure, we would all love to get rich, but the fact remains that we are investing in bio-science that our NIH does not.
I hope stem cell therapy helps you improve your quality of life.
I read this as super news. This is, after all, a govt. agency. Sellers here must never need the US Post Office.